Marksans Pharma Limited has informed the Exchange regarding a press release dated August 26, 2021, titled "Marksans Pharma Limited announces USFDA approval for Acetaminophen Extended-Release Tablets USP, 650 mg (OTC)".
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 26, 2021, titled "Marksans Pharma Limited announces USFDA approval for Acetaminophen Extended-Release Tablets USP, 650 mg (OTC)".